“An FDA inspector once said that any individual should be able to perform drug reconciliation at an investigative site within 20 minutes.” (2002 Applied Clinical Trials). Conducting a clinical trial with a drug or device that is not FDA approved or that is being used in an investigational manner can be daunting. A site must know the federal regulations, and have accountability practices. Learning about some best practices will make this task easier and more manageable.
Course Objectives:
This webinar will help clarify information to provide a foundation from which those responsible for investigational product accountability can build to avoid compliance issues and audit errors. We will discuss:
• The regulatory framework.
• Become familiar with investigational product best practices.
• Understand when a product is investigational.
• Know the research site’s responsibility.
Course Outline:
• 21 CFR 312
• 21 CFR 812
• Good Clinical Practice guideline requirements study conduct
• Requirements under an Investigational New Drug Number
• Tracking methods to assist with investigational product accountability
• Areas that can create audit findings
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Human Subjects Research
• Healthcare interested in exploring the field of Clinical Research
• Clinical Research Coordinators, Associates, and Managers
• Administration in charge of Clinical Research, Clinical Research Sites
• Contract Research Organizations ,
• Regulatory Coordinators
• Principal Investigator positions, Sub-Investigators
• Pharmacists
Professional Guidance on Conducting a Comprehensive HIPAA Risk Analysis
Get Instant Access 60 Minutes View Program |
Best Practices in Preparation for an FDA Computer System Audit
Get Instant Access 90 Minutes View Program |
Packaging and Labeling for Commercial and Clinical Products
Get Instant Access 90 Minutes View Program |
3 Hours Virtual Seminar: China Compliance Processes for Life Science Products: Company Establishment, Clinical Trials, Registrations, Renewals and Supply Chain Considerations
Get Instant Access 180 Minutes View Program |
Biopharmaceutic Considerations in Drug Product Design and In Vitro Drug Product Performance
Get Instant Access 90 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry